Abstract
This paper presents an analytical formulation for determining optimal pool size in the initial pooling stage and the subsequent retests for COVID-19. A generalized constant compaction approach confirms the efficiency of “halving” targeted population between retest stages. An analytical gain formula is derived to aid future test designs. It is observed that optimal gain relies on the proper choice of the initial pool size. This optimal compaction scheme outperforms the conventional algorithms in most cases and may provide a mathematically-native road map for us to operate beyond the standard super-even-number-based (64, 32, 16, 8…, 1) group testing algorithms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This paper was self-funded.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
stoshi715{at}gmail.com
Data Availability
All data is available upon request.
